 | $620,000.00 in Sales Expected for Arbutus Biopharma Corp (ABUS) This Quarter
www.americanbankingnews.com - November 11 at 8:34 AM |
| Investors Purchase High Volume of Arbutus Biopharma Call Options (ABUS)
www.americanbankingnews.com - November 9 at 6:52 AM |
| -$0.46 Earnings Per Share Expected for Arbutus Biopharma Corp (ABUS) This Quarter
www.americanbankingnews.com - November 9 at 3:22 AM |
| Arbutus Biopharma (ABUS) Releases Earnings Results, Misses Estimates By $0.13 EPS
www.americanbankingnews.com - November 8 at 8:15 PM |
 | Arbutus Biopharma Corp's (ABUS) CEO Mark Murray on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 8:20 AM |
| Arbutus Biopharma misses by $0.08
seekingalpha.com - November 7 at 5:49 PM |
 | Arbutus Reports 2018 Third Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - November 7 at 5:49 PM |
| Arbutus Biopharma (ABUS) to Release Earnings on Wednesday
www.americanbankingnews.com - November 1 at 11:54 AM |
| Arbutus to Report Third Quarter 2018 Financial Results
finance.yahoo.com - October 31 at 5:30 PM |
 | Arbutus Biopharma (ABUS) Q3 Earnings Preview: What to Expect
www.zacks.com - October 26 at 8:22 AM |
| Arbutus Biopharma Corp (ABUS) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - October 23 at 10:47 AM |
| Arbutus Names New Members to its Board of Directors
finance.yahoo.com - October 22 at 5:22 PM |
| What Kind Of Risk Should You Expect For Arbutus Biopharma Corporation (NASDAQ:ABUS)?
finance.yahoo.com - October 17 at 4:59 PM |
| Arbutus Bio down 24% on delay of early-stage study of HBV candidate AB-452
seekingalpha.com - October 9 at 4:57 PM |
| Why Arbutus Biopharma Stock Plunged 24.4% Today
finance.yahoo.com - October 9 at 4:57 PM |
| Here's Why Arbutus Biopharma Corp. Is Tanking Today
finance.yahoo.com - October 9 at 4:57 PM |
 | Here's Why Arbutus Biopharma Corp. Is Tanking Today
www.fool.com - October 9 at 3:28 PM |
| Arbutus to Present at Chardan’s Genetic Medicines Conference
finance.yahoo.com - October 2 at 4:52 PM |
| Are Options Traders Betting on a Big Move in Arbutus (ABUS) Stock?
www.zacks.com - September 24 at 8:16 AM |
| Arbutus to Participate at the 2018 B. Riley FBR Healthcare Conference
finance.yahoo.com - August 28 at 4:57 PM |
| More Volatility Ahead For Arbutus Biopharma
seekingalpha.com - August 17 at 5:36 PM |
| Alnylam Receives First Ever FDA Approval For RNAi Therapeutic Treating Rare Disease Making History
seekingalpha.com - August 13 at 8:13 AM |
 | Arbutus to Present at the 2018 Wedbush PacGrow Healthcare Conference
feeds.benzinga.com - August 9 at 8:40 AM |
| Arbutus down 16% after Q2 report
seekingalpha.com - August 3 at 4:34 PM |
| Arbutus Biopharma Corp (ABUS) CEO Mark Murray on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 3 at 8:23 AM |
| Arbutus Reports 2018 Second Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - August 2 at 5:32 PM |
| ContraVir Stock Rose on Clinical Trial Progress Report
finance.yahoo.com - July 24 at 8:38 AM |
| Arbutus Biopharma (ABUS) Shares March Higher, Can It Continue?
finance.yahoo.com - July 20 at 5:14 PM |
 | Arbutus to Report Second Quarter 2018 Financial Results
globenewswire.com - July 19 at 4:45 PM |
 | Opinion: Harry Boxer's three drug stocks to watch
www.marketwatch.com - July 19 at 4:45 PM |
| Arbutus: An Extremely Promising RNAi Innovator Hitting Its Growth Inflection
seekingalpha.com - July 19 at 8:15 AM |
| Arbutus Biopharma: Long-Term Growth Prospect Flying Too Close To The Sun
seekingalpha.com - July 18 at 4:52 PM |
| Arbutus Presents Corporate Update on Key Milestones
finance.yahoo.com - July 10 at 8:16 AM |
 | B.Riley/FBR Downgrades Arbutus Biopharma (ABUS) to Neutral
www.streetinsider.com - July 6 at 8:15 AM |
| Form 4 Arbutus Biopharma Corp For: Jun 19 Filed by: HENRIQUES RICHARD C JR
www.streetinsider.com - June 27 at 8:57 AM |
| Arbutus Biopharma: The Next Big Breakout Biotech?
seekingalpha.com - June 22 at 5:42 PM |
| Arbutus Biopharma to Present at First Annual Roivant Pipeline Day
finance.yahoo.com - June 18 at 8:50 AM |
| Arbutus appoints David C. Hastings as new Chief Financial Officer
seekingalpha.com - June 8 at 8:17 AM |
| Arbutus Biopharma (ABUS) Announces Appointment of David C. Hastings as New Chief Financial Officer
www.streetinsider.com - June 8 at 8:17 AM |
| Arbutus Biopharma's (ABUS) CEO Mark Murray on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 6 at 7:42 PM |
| Arbutus Biopharma (ABUS) Reports Q1 Loss of $0.36/Share
www.streetinsider.com - May 4 at 5:34 PM |
 | BRIEF-Arbutus Reports Q1 Loss Per Share $0.36
www.reuters.com - May 4 at 8:18 AM |
| Arbutus: 1Q Earnings Snapshot
finance.yahoo.com - May 4 at 8:18 AM |
| Arbutus Biopharma beats by $0.03, beats on revenue
seekingalpha.com - May 3 at 5:25 PM |
| Arbutus Announces Corporate Update and First Quarter 2018 Financial Results
finance.yahoo.com - May 3 at 5:25 PM |
| Merck Teams With Moderna To Take On One Of The Toughest Targets In Cancer
finance.yahoo.com - May 3 at 5:25 PM |
| Arbutus Announces Conference Call to Provide a Corporate Update and First Quarter 2018 Financial Results
finance.yahoo.com - April 30 at 5:14 PM |
| BRIEF-Arbutus And Roivant Launch Genevant Sciences With Platform To Develop Broad Range Of RNA Therapeutics ...
www.reuters.com - April 13 at 5:33 PM |
| Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA ...
globenewswire.com - April 13 at 5:33 PM |
| Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at ...
globenewswire.com - April 13 at 5:33 PM |
